Information and Communications Technology Industry in Latvia

21 Manufacture of basic pharmaceutical products and pharmaceutical preparations

LARIFĀNS LTD

General Information
Registration number: 
40003365497
Year of foundation: 
1997
Industry (NACE 2): 
MANUFACTURING
20 Manufacture of chemicals and chemical products
20.4 Manufacture of soap and detergents, cleaning and polishing preparations, perfumes and toilet preparations
20.42 Manufacture of perfumes and toilet preparations
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 Manufacture of pharmaceutical preparations
21.20 Manufacture of pharmaceutical preparations
Number of employees: 
11 - 20
Turnover (EUR):
400 001 - 500 000
2020
400 001 - 500 000
2019
Export volume (EUR):
No data
2020
No data
2019
Export countries: 
Azerbaijan
Estonia
Georgia
Lithuania
Ukraine
Head of the Company
Name, surname: 
Ms Guna Feldmane - Member of the Board/Director
Contact Information
Address: 
Kurbada iela 2B, Rīga, LV-1009, Latvia
Phone: 
+371-67427462
Fax: 
+371-67427462
E-mail: 
info [at] larifans.lv
Contact persons' name, surname: 
Mr Nauris Leja - Member of the Board
Languages spoken : 
English
German
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

Larifāns produces medical products and cosmetics based on the pharmaceutically active substance dsRNA Larifan.

This unique, active substance was developed at Latvia’s Institute of Microbiology in the 1980s. Commercial products based on dsRNS Larifan have been made since 1994. Larifan is an immunomodulator, interferon inducer of natural origin with a broad spectrum of action. Larifan is used in fields including immunology, virology and oncology.

Larifan is widely used as antiviral and immunomodulating agent in different viral diseases causing herpes, influenza, encephalitis, hepatitis, papilloma (warts) and different sexually transmissible diseases. In gynaecology, Larifan is widely used for the treatment of cervical dysplasia. Larifan is also used for the correction of secondary immunodeficiency and in oncology as a component of biotherapeutic courses of treatment.
 

Target export countries: 
Georgia
Ukraine
Cooperation interests: 

We are interested in cooperation with pharmaceutical and medical companies, with pharmacies, clinics and hospitals who are interested in the distribution of Larifan.

OLAINFARM

General Information
Registration number: 
40003007246
Year of foundation: 
1991
Industry (NACE 2): 
MANUFACTURING
20 Manufacture of chemicals and chemical products
20.1 Manufacture of basic chemicals, fertilisers and nitrogen compounds, plastics and synthetic rubber in primary forms
20.5 Manufacture of other chemical products
20.59 Manufacture of other chemical products n.e.c.
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 Manufacture of pharmaceutical preparations
21.20 Manufacture of pharmaceutical preparations
Number of employees: 
1 001 - 2 000
Turnover (EUR):
50 000 001 - ...
2020
50 000 001 - ...
2019
Export volume (EUR):
50 000 001 - ...
2020
50 000 001 - ...
2019
Export countries: 
Australia
Belarus
Bulgaria
Canada
Germany
Kazakhstan
Lithuania
Poland
Russia
Ukraine
United Kingdom
United States of America
Uzbekistan
Certificates: 
ISO 14001, ISO 17025 Laboratory Management System, EU GMP for APIs and FDFs, US cGMP for certain APIs (FDA), TGA for FDFs (Australia).
Contact Information
Address: 
Rūpnīcu iela 5, Olaine, Olaines nov., LV-2114, Latvia
Phone: 
+371-67013705
Fax: 
+371-67013777
E-mail: 
olainfarm [at] olainfarm.lv
Languages spoken : 
English
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

Production and sales of finished dosage forms (FDF), active pharmaceutical ingredients (API), intermediates and chemicals.

Olainfarm manufactures more than 60 FDFs in various forms. Key areas of specialisation include neurology (cholinesterase inhibitors, anxiolytics, psychostimulants, nootropics), cardiology (antiarrhythmics, energy metabolism enhancers), infectology (original nitrofurantoine derivatives and antivirals) and allergology (fast-acting antihistamines).

Olainfarm produces 28 different APIs and more than 20 intermediates and chemicals. The company is experienced in adamantane derivatives, quinuclidine derivatives, nitrofuran derivatives and optically pure g-aminobutyric acid derivatives, as well as in chiral compounds.

 

* The company participates in the In-depth Cooperation Programme and has been admitted to the Gold level.

Target export countries: 
Australia
Belarus
Bulgaria
Canada
Germany
Kazakhstan
Lithuania
Poland
Russia
Ukraine
United Kingdom
United States of America
Uzbekistan
Cooperation interests: 

Outsourcing of analytical services, contract manufacturing, licensing of active substances.

SILVANOLS

General Information
Registration number: 
40003233170
Year of foundation: 
1994
Industry (NACE 2): 
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 Manufacture of pharmaceutical preparations
21.20 Manufacture of pharmaceutical preparations
32 Other manufacturing
32.5 Manufacture of medical and dental instruments and supplies
32.50 Manufacture of medical and dental instruments and supplies
Number of employees: 
51 - 100
Turnover (EUR):
5 000 001 - 10 000 000
2018
4 000 001 - 5 000 000
2017
Export volume (EUR):
500 001 - 1 000 000
2018
1 000 001 - 2 000 000
2017
Export countries: 
Azerbaijan
Belarus
Czech Republic
Estonia
Georgia
Kazakhstan
Kosovo
Lithuania
North Macedonia
Poland
Romania
Russia
Certificates: 
ISO 9001, ISO 22000, cGMP
Head of the Company
Name, surname: 
Ms Liene Puriņa - Chairwoman of the Board
Contact Information
Address: 
Kurbada iela 2A, Rīga, LV-1009, Latvia
Phone: 
+371-67142829
Fax: 
+371-67142833
E-mail: 
info [at] silvanols.lv
Contact persons' name, surname: 
Ms Līva Pildava - Export Manager
Languages spoken : 
English
Latvian
Russian
Swedish
Business Profile and Cooperation Interests
Business profile: 

Silvanols products are exported to more than 13 countries.

Our product portfolio consists of a unique range of original herbal products – OTCs, medical devices and food supplements.

The main product lines cover cold remedies and the respiratory system health, cardiovascular health, liver and digestive system health, mental and nervous system health, vitamins and minerals, muscle, joint and vein system health, men’s health, products for children.

Product forms: balsams, gels, sprays, drops, capsules, tablets.

Services offered: contract manufacturing, laboratory services and product development

 

Target export countries: 
Azerbaijan
Belarus
Bosnia and Herzegovina
Czech Republic
Estonia
Georgia
Hungary
Kazakhstan
Lithuania
North Macedonia
Poland
Russia
Cooperation interests: 

Marketing and distribution partnerships in export markets, contract manufacturing. 

Pages

Subscribe to 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations